Aromatase Inhibitors as Neoadjuvant Treatment in Elderly Patients with Locally Advanced Breast Cancer
Lucia Borgato, Silvia Michieletto(Istituto Oncologico Veneto), Vittorina Zagonel(Istituto Oncologico Veneto), Antonella Brunello(Istituto Oncologico Veneto), Tania Saibene(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 0
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569